Farnesylthiosalicylic acid (salirasib) inhibits Rheb in TSC2-null ELT3 cells: a potential treatment for lymphangioleiomyomatosis.
about
Optimizing treatments for lymphangioleiomyomatosisManagement of lymphangioleiomyomatosisLovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome.Drugging the undruggable RAS: Mission possible?Analysis of gene expression array in TSC2-deficient AML cells reveals IRF7 as a pivotal factor in the Rheb/mTOR pathway.Ras and autophagy in cancer development and therapy.Lymphangioleiomyomatosis: New Treatment Perspectives.Notch transactivates Rheb to maintain the multipotency of TSC-null cells.Is Ras a potential target in treatment against cutaneous squamous cell carcinoma?
P2860
Q26865250-FBE8FA48-2898-47DF-88BB-D8D33FD6A72DQ28084725-89AAC12B-57A8-44B4-83B4-93EC1C6FAEEBQ30537599-16822514-2657-4C18-9C9B-E85B14B24D84Q35163434-D7925D98-3F7F-4939-A7DA-49281AB0588BQ36291973-062BBB94-25D5-4CC9-88F1-40FF0E049A4BQ38192416-B28B0B45-E8A3-4B74-A857-A8F7B28F7CE3Q38484497-75AF2329-6A5C-4F05-87B9-694CE811982FQ47303044-6D62C5AF-8B61-4B63-86FF-624B96AFB733Q57116365-A256759A-AFCD-4BEE-9C76-ACC7EF5C545A
P2860
Farnesylthiosalicylic acid (salirasib) inhibits Rheb in TSC2-null ELT3 cells: a potential treatment for lymphangioleiomyomatosis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Farnesylthiosalicylic acid (sa ...... for lymphangioleiomyomatosis.
@en
Farnesylthiosalicylic acid
@nl
type
label
Farnesylthiosalicylic acid (sa ...... for lymphangioleiomyomatosis.
@en
Farnesylthiosalicylic acid
@nl
prefLabel
Farnesylthiosalicylic acid (sa ...... for lymphangioleiomyomatosis.
@en
Farnesylthiosalicylic acid
@nl
P2093
P2860
P356
P1476
Farnesylthiosalicylic acid (sa ...... for lymphangioleiomyomatosis.
@en
P2093
Roni Haklai
Victoria Makovski
Yoel Kloog
P2860
P304
P356
10.1002/IJC.26139
P577
2011-08-01T00:00:00Z